Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jia J Li

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cold Spring Harbor Perspectives in Medicine|October 7, 2018
Prostate Stem Cells and Cancer Stem CellsJia J Li, Michael M Shen
Seminars in Ultrasound, CT, and MR|December 6, 2023
Point of Care Abdominal UltrasoundJia J Li, Zachary Boivin, Sonali Bhalodkar, et al.
Diseases of the Colon and Rectum|March 12, 2021
Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded StudyTing Wang, Wenjun Pan, Hang Zheng, et al.
The AAPS Journal|March 16, 2018
Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison with an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based AssayYuling Wu, Ahmad Akhgar, Jia J Li, et al.
Infection and Immunity|December 22, 2017
Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient PopulationsYuling Wu, Xu Liu, Ahmad Akhgar, et al.
The AAPS Journal|July 25, 2015
A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated CytotoxicityYuling Wu, Jia J Li, Hyun Jun Kim, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancerJia J Li, Alessandro Vasciaveo, Dimitrios Karagiannis, et al.
Nature|November 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Nature|July 1, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cold Spring Harbor Perspectives in Medicine|October 7, 2018
Prostate Stem Cells and Cancer Stem CellsJia J Li, Michael M Shen
Seminars in Ultrasound, CT, and MR|December 6, 2023
Point of Care Abdominal UltrasoundJia J Li, Zachary Boivin, Sonali Bhalodkar, et al.
Diseases of the Colon and Rectum|March 12, 2021
Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded StudyTing Wang, Wenjun Pan, Hang Zheng, et al.
The AAPS Journal|March 16, 2018
Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison with an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based AssayYuling Wu, Ahmad Akhgar, Jia J Li, et al.
Infection and Immunity|December 22, 2017
Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient PopulationsYuling Wu, Xu Liu, Ahmad Akhgar, et al.
The AAPS Journal|July 25, 2015
A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated CytotoxicityYuling Wu, Jia J Li, Hyun Jun Kim, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancerJia J Li, Alessandro Vasciaveo, Dimitrios Karagiannis, et al.
Nature|November 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Nature|July 1, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Pageof 1